Making Decisions About Krabbe Disease Newborn Screening
Pediatrics
.
2022 Aug 1;150(2):e2022057888.
doi: 10.1542/peds.2022-057888A.
Authors
Joanne Kurtzberg
1
,
Dietrich Matern
2
,
Joseph J Orsini
3
,
Michael Gelb
4
,
Stacy Pike-Langenfeld
5
,
Lesa Brackbill
6
,
Anna Grantham
7
,
Anthony C Steyermark
8
Affiliations
1
Duke University School of Medicine, Durham, North Carolina.
2
Mayo Clinic College of Medicine, Rochester, Minnesota.
3
New York State Department of Health, Wadsworth Center, Albany, New York.
4
University of Washington, Seattle, Washington.
5
Krabbe Connect, Rosemount, Minnesota.
6
Leukodystrophy Newborn Screening Action Network, Hershey, Pennsylvania.
7
Hunter's Hope Foundation, Orchard Park, New York.
8
The Legacy of Angels Foundation, Rosemount, Minnesota.
PMID:
35896799
DOI:
10.1542/peds.2022-057888A
No abstract available
Publication types
Letter
Comment
MeSH terms
Decision Making
Humans
Infant, Newborn
Leukodystrophy, Globoid Cell* / diagnosis
Neonatal Screening